Market Research Reports

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast 2010 - 2017

130pages
Published Date: 2012-11-17
 

Description




This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report segregates the infertility drugs and devices industry in terms of products, technology and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global infertility drugs and devices market and further validated numbers with the key market participants and C-level executives. 

This report highlights the industry with the following points:
  • Definition, estimates and forecast of infertility drugs and devices market from 2010 to 2017
  • Analysis of product segments for infertility drugs and devices market with historical data and forecast
  • Trends and forecast for four geographic markets, namely North America, Europe, Asia Pacific and the RoW regions based on segments of infertility drugs and devices market
  • Profiles of major market participants for better understanding of their contributions
This research is specially designed to estimate and analyze the demand and performance of infertility drugs and devices in a global scenario. The research provides in-depth analysis of infertility drugs and devices manufacturers, product sales, trend analysis by segments and demand by geography. The report covers all the major product segments of the global infertility drugs and devices market and provide in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global infertility drugs and devices market as below:

Infertility Drugs and  Devices Market by Types

Female
  • Endometriosis
  • Ovarian Disorders
  • Uterine Disorders
  • Tubal Disorders
  • Hormonal Disorders
Male
  • Azoospermia
  • Varicocele
  • Ejaculation Disorder
  • Erectile Dysfunction
Infertility Drugs and  Devices by Technology
  • Assisted Reproductive Technologies
  • In Vitro Fertilization
  • Artificial Insemination
  • Surgery 
Infertility Drugs and  Devices Market by Geography

Europe Infertility Drugs and Devices Market
  • U.K
  • France
  • Germany
  • Italy
  • Spain
North America Infertility Drugs And Devices Market
  • U.S
  • Canada
  • Mexico
Asia Pacific Infertility Drugs And Devices Market
  • Japan
  • India
  • China
Row Infertility Drugs And Devices Market
  • Brazil 
The in-depth research and high level analysis will allow infertility drugs and device manufacturers, lawmakers, large retailers, medical companies and research and development agencies to make informed decisions about infertility drugs and devices manufacturing, designing marketing, growth strategies and gaining competitive advantage.

Table of Contents




TABLE OF CONTENTS

CHAPTER 1 PREFACE
1.1 KEY POINTS COVERED
1.2 REPORT DESCRIPTION
1.3 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY AND MARKET OVERVIEW

CHAPTER 3 INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS
3.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017
      3.1.1 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET, 2010 V/S 2017
      3.1.2 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017
      GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017
3.2 POPULATION GROWTH TREND
      3.2.1 GLOBAL MALE AND FEMALE POPULATION GROWTH TREND BY AGE GROUP
      3.2.2 INFERTILITY DRUGS AND DEVICES MARKET ATTRACTIVENESS ANALYSIS BY GEOGRAPHY
3.3 CAUSES OF INFERTILITY
3.4 MARKET DYNAMICS
      3.4.1 DRIVERS
              3.4.1.1 Rising number of infertile people
              3.4.1.2 Increasing worldwide obesity
              3.4.1.3 Rising disposable incomes of the consumers
              3.4.1.4 Lifestyle hazards such as rising number of smokers, stress and pollution
              3.4.1.5 Adoption of babies by homosexual couples
              3.4.1.6 Availability of government support for infertility abatement procedures
      3.4.2 INFERTILITY DRUGS AND DEVICES MARKET DRIVER IMPACT ANALYSIS
      3.4.3 RESTRAINTS
              3.4.3.1 Limited insurance covers
              3.4.3.2 Religious bans on artificial insemination procedures especially the Islamic bans
              3.4.3.3 Risk of repeat procedures
              3.4.3.4 Traditional infertility treatments such as the Chinese infertility treatments
              3.4.3.5 Ban on artificial reproduction procedures in European countries especially Turkey, Germany, Italy and France
              3.4.3.6 Patent expiration of infertility drugs
      3.4.4 INFERTILITY DRUGS AND DEVICES MARKET RESTRAINTS IMPACT ANALYSIS
      3.4.5 OPPORTUNITY
              3.4.5.1 Technological advancements in the Asia Pacific region and the developmental activities in the region
              3.4.5.2 Medical tourism initiatives in the developing countries
              3.4.5.3 Need for more ART cycles
3.1 MARKET SHARE ANALYSIS, 2011
3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET
      3.2.1 BARGAINING POWER OF SUPPLIERS
      3.2.1 BARGAINING POWER OF BUYERS
      3.2.2 THREAT OF NEW ENTRANTS
      3.2.3 THREAT OF SUBSTITUTES
      3.2.4 COMPETITIVE RIVALRY

CHAPTER 4 INFERTILITY DRUGS AND DEVICES MARKET SEGMENTATION
4.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY TYPES
      4.1.1 FEMALE INFERTILITY POPULATION PREVALENCE BY TYPES
              4.1.1.1 Global Infertility drugs and devices market by Endometriosis female infertility types
              4.1.1.2 Global Infertility drugs and devices market by Ovarian disorder female infertility types
              4.1.1.3 Global Infertility drugs and devices market by Uterine disorder female infertility types
              4.1.1.4 Global Infertility drugs and devices market by Tubal disorder female infertility types
              4.1.1.5 Global Infertility drugs and devices market by Hormonal disorder female infertility types
     4.1.2 MALE INFERTILITY POPULATION PREVALENCE BY TYPES
              4.1.2.1 Global Infertility drugs and devices market by Azoospermia male infertility types
              4.1.2.2 Global Infertility drugs and devices market by Varicocele male infertility types
              4.1.2.3 Global Infertility drugs and devices market by Ejaculation Disorder male infertility types
              4.1.2.4 Global Infertility drugs and devices market by Erectile Dysfunction male infertility types
4.2 INFERTILITY DRUGS AND DEVICES MARKET BY TECHNOLOGY
      4.2.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION
      4.2.2 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ASSISTED REPRODUCTIVE TECHNOLOGIES (USD THOUSAND) 
      4.2.3 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY IN VITRO FERTILIZATION (USD THOUSAND) 
      4.2.4    GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY SURGERY (USD THOUSAND) 57

CHAPTER 5 REGION-WISE ANALYSIS
5.1 INFERTILITY DRUGS AND DEVICES MARKET BY REGION
      5.1.1 EUROPE INFERTILITY DRUGS AND DEVICES MARKET
              5.1.1.1 U.K
              5.1.1.2 France
              5.1.1.3 Germany
              5.1.1.4 Italy
              5.1.1.5 Spain
     5.1.2 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
     5.1.3 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
              5.1.3.1 U.S
              5.1.3.2 CANADA
              5.1.3.3 MEXICO
     5.1.4 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
     5.1.5 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
              5.1.5.1 Japan
              5.1.5.2 India
              5.1.5.3 China
     5.1.6 ROW INFERTILITY DRUGS AND DEVICES MARKET
     5.1.7 ROW INFERTILITY DRUGS AND DEVICES MARKET
              5.1.7.1 Brazil’s Infertility drugs and devices market

CHAPTER 6 COMPANY PROFILES
6.1 JOHNSON & JOHNSON
      6.1.1 COMPANY OVERVIEW
      6.1.2 FINANCIAL OVERVIEW
      6.1.3 BUSINESS STRATEGIES
      6.1.4 RECENT DEVELOPMENTS
6.2 MERCK
      6.2.1 COMPANY OVERVIEW
      6.2.2 FINANCIAL OVERVIEW
      6.2.3 BUSINESS STRATEGIES
      6.2.4 PRODUCT PORTFOLIO
      6.2.5 RECENT DEVELOPMENT
6.3 TEVA PHARMACEUTICALS
      6.3.1 COMPANY OVERVIEW
      6.3.2 FINANCIAL OVERVIEW
      6.3.3 BUSINESS STRATEGIES
      6.3.4 PRODUCT PORTFOLIO
      6.3.5 RECENT DEVELOPMENTS
6.4 ORIGIO
      6.4.1 COMPANY OVERVIEW
      6.4.2 FINANCIAL OVERVIEW
      6.4.3 BUSINESS STRATEGIES
      6.4.4 PRODUCT PORTFOLIO
      6.4.5 RECENT DEVELOPMENTS
6.5 BAYER
      6.5.1 COMPANY OVERVIEW
      6.5.2 FINANCIAL OVERVIEW
      6.5.3 BUSINESS STRATEGIES
      6.5.4 PRODUCT PORTFOLIO
      6.5.5 RECENT DEVELOPMENT

LIST  OF  FIGURES

FIG.  1  GLOBAL  INFERTILITY  DRUGS  AND  DEVICES  MARKET  REVENUE  (USD  THOUSAND)  AND  ANNUAL  GROWTH  RATE,  2010  –  2017  (%)  
FIG.  2  COMPARATIVE  ANALYSIS  OF  GLOBAL  INFERTILITY  DRUGS  AND  DEVICES  MARKET  SHARE,  2010  VS  2017  
FIG.  3  GLOBAL  INFERTILITY  DRUGS  MARKET  REVENUE,  2010  –  2017  (USD  THOUSAND),  ANNUAL  GROWTH  RATE,  2010  –  2017  (%)  
FIG.  4  GLOBAL  POPULATION  TREND,  MALE  AND  FEMALE  POPULATION  TREND,  2010  –  2017  (THOUSANDS)  
FIG.  5  GLOBAL  FERTILE  MALE  AND  FEMALE  POPULATION  TREND,  2010  –  2017  (THOUSANDS)  
FIG.  6  GLOBAL  INFERTILITY  DEVICES  MARKET  REVENUE,  2010  –  2017  (USD  THOUSAND),  ANNUAL  GROWTH  RATE,  2010  –  2017  (%)  
FIG.  7  MARKET  ATTRACTIVENESS  -  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  GEOGRAPHY  
FIG.  8  CAUSES  OF  INFERTILITY  
FIG.  9  PORTER’S  FIVE  FORCES  ANALYSIS  FOR  THE  INFERTILITY  DRUGS  AND  DEVICES  MARKET  
FIG.  10  COMPARITIVE  ANALYSIS  OF  INFERTILITY  DRUGS  AND  DEVICES  MARKET  SHARE  BY  GEOGRAPHY,  2010  AND  2017  (%)  
FIG.  11  EUROPE  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND),  ANNUAL  GROWTH  RATE,  2010  –  2017  (%)  
FIG.  12  NORTH  AMERICA  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND),  ANNUAL  GROWTH  RATE,  2010  –  2017  (%)  
FIG.  13  ASIA  PACIFIC  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND),  ANNUAL  GROWTH  RATE,  2010  –  2017  (%)  
FIG.  14  DECLINING  FERTILITY  RATE  IN  JAPAN,  2007  -  2011  
FIG.  15  ROW  INFERTILITY  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND),  ANNUAL  GROWTH  RATE,  2010  –  2017  (%)  
FIG.  16  JOHNSON  &  JOHNSON’S  ANNUAL  SALES,  2007  –  2011  (USD  MILLION),  ANNUAL  GROWTH  RATE,  2007  –  2010  (%)  
FIG.  17  MERCK’S  ANNUAL  REVENUE,  2007  –  2011  (USD  MILLION),  ANNUAL  GROWTH  RATE,  2007  -  2010  (%)  
FIG.  18  TEVA  PHARMACEUTICAL’S  ANNUAL  REVENUE,  2007  –  2011  (USD  MILLION),  ANNUAL  GROWTH  RATE,  2007  -  2010  (%)  
FIG.  19  ORIGIO’S  ANNUAL  REVENUE,  2010  –  2011  (USD  MILLION)  
FIG.  20  BAYER’S  ANNUAL  SALES,  2010  –  2011  (USD  MILLION)  

LIST  OF  TABLES

TABLE  1  IMPACT  ANALYSIS  OF  DRIVERS
TABLE  2  IMPACT  ANALYSIS  OF  RESTRAINTS
TABLE  3  GLOBAL  FEMALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND  )  
TABLE  4  GLOBAL  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND  )  
TABLE  5  GLOBAL  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND)  
TABLE  6  U.K    INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  7  U.K  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  8  U.K  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  9  U.K  FEMALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND  )  
TABLE  10  U.K  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  11  U.K  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND  )  
TABLE  12  FRANCE  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  13  FRANCE  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  14  FRANCE  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  15  FRANCE  FEMALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND  )  
TABLE  16  FRANCE  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  17  FRANCE  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND  )  
TABLE  18  GERMANY  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  19  GERMANY  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  20  GERMANY  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  21  GERMANY  FEMALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND  )  
TABLE  22  GERMANY  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  
TABLE  23  GERMANY  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND  )  
TABLE  24  ITALY  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  25  ITALY  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  26  ITALY  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  27  ITALY  FEMALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND  )  
TABLE  28  ITALY  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  29  ITALY  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND  )  
TABLE  30  SPAIN  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  31  SPAIN  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  32  SPAIN  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  33  SPAIN  FEMALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND  )  
TABLE  34  SPAIN  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  35  SPAIN  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND  )  
TABLE  36  U.S  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  37  U.S  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  38  U.S  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  39  U.S  MALE  INFERTILITY  POPULATION  TREATED,  2010  -  2017  (THOUSAND)  
TABLE  40  U.S  FEMALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  41  U.S  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  42  U.S  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND)  
TABLE  43  CANADA  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  44  CANADA  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  45  CANADA  MALE  INFERTILITY  POPULATION  PREVALENCE  2010  -  2017  (THOUSAND)  
TABLE  46  CANADA  FEMALE  INFERTILITY  POPULATION  PREVALENCE,  2010  –  2017  (THOUSAND)  
TABLE  47  CANADA  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  48  CANADA  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND)  
TABLE  49  MEXICO  INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  50  MEXICO  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  51  MEXICO  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  52  MEXICO  FEMALE  INFERTILITY  POPULATION  PREVALENCE  AND  TREATED,  2010  -  2017  (THOUSAND)  
TABLE  53  MEXICO  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  54  MEXICO  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND)  
TABLE  55  JAPAN    INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  56  JAPAN  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  57  JAPAN  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  58  JAPAN  FEMALE  INFERTILITY  POPULATION  PREVALENCE  AND  TREATED,  2010  -  2017  (MILLION)  
TABLE  59  JAPAN  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  60  JAPAN  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  MILLION)  
TABLE  61  INDIA    INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  62  INDIA  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  63  INDIA  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND
TABLE  64  INDIA  FEMALE  INFERTILITY  POPULATION  PREVALENCE  AND  TREATED,  2010  -  2017  (THOUSAND)  
TABLE  65  INDIA  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  66  INDIA  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND)  
TABLE  67  CHINA    INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  68  CHINA  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  69  CHINA  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  70  CHINA  FEMALE  INFERTILITY  POPULATION  PREVALENCE  AND  TREATED,  2010  -  2017  (THOUSAND  )  
TABLE  71  CHINA  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  72  CHINA  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND  )  
TABLE  73  ROW    INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  74  ROW  FEMALE  INFERTILITY  POPULATION  PREVALENCE  AND  TREATED,  2010  -  2017  (THOUSAND  )  
TABLE  75  ROW  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND  )  
TABLE  76  BRAZIL    INFERTILITY  DRUGS  AND  DEVICES  MARKET,  2010  –  2017  (USD  THOUSAND)  
TABLE  77  BRAZIL  POPULATION  BY  DEMOGRAPHICS,  2010  -  2017  (THOUSAND)  
TABLE  78  BRAZIL  MALE  INFERTILITY  POPULATION  PREVALENCE,  2010  -  2017  (THOUSAND)  
TABLE  79  BRAZIL  FEMALE  INFERTILITY  POPULATION  PREVALENCE  AND  TREATED,  2010  -  2017  (THOUSAND  )  
TABLE  80  BRAZIL  INFERTILITY  DRUGS  AND  DEVICES  TECHNOLOGY  MARKET  REVENUE  BY  FERTILITY  TYPE,  2010  –  2017  (USD  THOUSAND  )  
TABLE  81  BRAZIL  INFERTILITY  DRUGS  AND  DEVICES  MARKET  BY  ARTIFICIAL  INSEMINATION  TECHNOLOGY,  2010  –  2017  (USD  THOUSAND  )  

Market Overview




Female infertility and male infertility is affecting a lot of couples nowadays, owing to the changing lifestyles and eating habits. More than 13% of couples are infertile; this means that they are trying to have a baby for more than a year. Chances of infertility arise in woman more than 35 years in age. The major reason behind infertility is ovulation disorders, as more than 25% couples are infertile due to this disorder.

The report analyses infertility drugs and devices market growth rate, industry capacity and industry structure. The report analyses the historical data and forecasts the infertility drugs and devices market size, production forecasts along with key factors driving and restraining the market. The report also contains In-depth geographic as well as trend analysis.

Enquiry Before Buying




 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research